chartexchange

FULC
Fulcrum Therapeutics, Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 3:29:53 PM EST
3.71USD-0.134%(-0.01)434,509
3.7100Bid3.7200Ask0.0100Spread

FULC Financials

In Q3 FY 2026 (ended ), Fulcrum Therapeutics, Inc. Common Stock (FULC) reported revenue of $0, net income of −$10.94M, operating cash flow of −$13.38M, and assets of $310.81M (filed ).

Loading financial statements…